CYCLERION THERAPEUTICS INC CYCN 深 滬
等待開盤 09-10 09:30:00 美东时间
2.60
+0.340
+15.04%
華盛通- 最 高2.62
- 今 開2.30
- 成交量 3.45万股
- 最 低 2.30
- 昨 收 2.26
- 總市值 867.72万
- 52周最高 9.4699
- 市盈率 靜 --
- 換手率 1.04%
- 52周最低 1.27
- 委 比 -71.06%
- 總股本 333.74万
- 歷史最高 296.60
- 量 比 1.81
- 振 幅 14.16%
- 歷史最低 1.27
- 每 手 1
- 風險率 0.47%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers iSpecimen (NASDAQ:ISPC) shares increased by 80.7% to $1.35 during Tues...
今天 01:06
Cycurion Inc. Regains Compliance with Nasdaq Listing Requirements
Cycurion Inc. (NASDAQ: CYCU) has regained compliance with Nasdaq Listing Rules following a notification on August 19, 2025, confirming the company meets the $10 million stockholders' equity requirement. Additionally, on August 20, 2025, the company was informed that it has satisfied the $5 million market value of publicly held shares rule. This resolves the previous notice of non-compliance regarding the market value of listed securities rule. Cy...
08-21 20:15
IQST - IQSTEL and Cycurion (CYCU) Sign MOU for Equity Exchange and Alliance to Build a Next-Gen AI-Driven Powerhouse with Half of the Stock to be Distributed as a Dividend to Shareholders
IQSTEL Inc. and Cycurion Inc. have signed an MOU to become mutual equity partners via a $1 million stock exchange, with 50% of shares distributed as dividends to enhance shareholder value. The collaboration combines IQSTEL's global telecom presence with Cycurion's U.S. market strength in government and institutional sectors. Together, they aim to develop advanced AI-driven cybersecurity solutions, boost innovation, and expand cross-selling opport...
08-07 12:45
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers BiomX (AMEX:PHGE) shares moved upwards by 40.1% to $0.61 during Tuesda...
08-06 05:07
Cyclerion Therapeutics shares are trading lower. The company reported Q2 financial results.
Cyclerion Therapeutics shares are trading lower. The company reported Q2 financ...
08-06 04:49
Cyclerion Therapeutics Q2 EPS $(0.11) Up From $(0.53) YoY, Sales $96.00K
Cyclerion Therapeutics (NASDAQ:CYCN) reported quarterly losses of $(0.11) per share. This is a 79.25 percent increase over losses of $(0.53) per share from the same period last year. The company reported $96.00 thousand
08-06 04:48
Cycurion (NASDAQ: CYCU) Launches “Cycurion Crypto” Subsidiary with $10 Million Treasury Allocation to Acquire Ethereum and Bitcoin
Cycurion, Inc. announced the formation of Cycurion Crypto, a wholly owned subsidiary, to expand its presence in the digital asset ecosystem. The company plans to allocate $10 million from its equity line of credit to establish a crypto treasury, primarily investing in Bitcoin (BTC) and Ethereum (ETH) as long-term holdings. This strategy aims to diversify its cash reserves, enhance shareholder value, and position the company for opportunities in b...
07-15 12:00
Cycurion Announces Continued Listing and Trading of its Common Stock and Warrants on NASDAQ
Cycurion, Inc. (Nasdaq: CYCU), a leader in IT cybersecurity and AI solutions, announced that its common stock and warrants continue to trade on NASDAQ under symbols "CYCU" and "CYCUW." This follows the SEC's filing to remove Western Acquisition Ventures Corp's units from listing, prior to its merger with Cycurion. Cycurion specializes in cybersecurity, program management, and business continuity, leveraging AI-enhanced platforms to serve governme...
06-06 18:15
Cyclerion Therapeutics announces mixed shelf offering
Cyclerion Therapeutics (NASDAQ:CYCN) plans to offer up to $25M in securities, including common stock, preferred stock, warrants, and units, through one or more series or classes. The company may sell ...
02-05 06:03
3 Penny Stocks to Watch Now, 2/4/25
Tarena International, Cyclerion Therapeutics, and Signing Day Sports are the 3&...
02-04 16:03
